Acquisition expands Day One’s portfolio with novel antibody-drug conjugate (ADC) emiltatug ledadotin (Emi-Le)Emi-Le has ...

LAVA shareholders who have not yet tendered their common shares may still tender during the subsequent offering period, which will expire one minute after 11:59 p.m. Eastern Time on November 20, 2025.

Merck , known as MSD outside of the United States and Canada, and Cidara Therapeutics, Inc. ("Cidara"), a biotechnology company developing drug-Fc conjugate (DFC) therapeutics, today announced that ...

LAVA Therapeutics N.V. ("LAVA") (Nasdaq: LVTX) today announced that 22,877,463 of LAVA's common shares, representing approximately ...

Acquisition expands Day One's portfolio with novel antibody-drug conjugate (ADC) emiltatug ledadotin (Emi-Le) Emi-Le has demonstrated early anti-tumor activity in an ongoing Phase 1 study for adenoid ...

The following is the Defense Department’s Acquisition Transformation Strategy, released Nov. 7, 2025.  From the Report Introduction The Defense Department is rapidly transforming our antiquated ...

Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on the development of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical ...

What FBS teams are the best on defense through Week 11 of college football? See below, because rankings across several stats are provided for you. Is your favorite team represented? Check out the ...

RALEIGH, N.C. -- It's a changing of the guard — and a shift in how the team will guard. After nearly a decade of Kevin Keatts leading NC State men's basketball, a new face is taking charge in Raleigh.